New study tests extra treatments for kids whose nearsightedness keeps getting worse despite special lenses
NCT ID NCT07494799
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will enroll about 3,890 children aged 8-12 who still have rapidly worsening nearsightedness (myopia) even after using orthokeratology (Ortho-K) lenses. Researchers will compare four approaches: continuing Ortho-K alone, adding low-dose atropine eye drops, using lenses with a smaller optical zone, or adding low-intensity red light therapy. The goal is to see which strategy best slows the lengthening of the eye over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 0.01% atropine sulfate eye drops; low-intensity red light therapy
- What this could lead to
- If successful, this could identify the best way to slow worsening nearsightedness in children who still progress despite wearing orthokeratology lenses.
- What could go wrong
- This is a prospective study that hasn't started recruiting yet. Results may not apply to all children, and some interventions (like atropine drops or red light) may cause side effects such as eye irritation or discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORTHOKERATOLOGY-RELATED MYOPIA PROGRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.